Print version of this report
Type of Product Medical Device
TGA Recall Reference RC-2016-RN-01011-1
Product Name/Description Various Kits containing Anticoagulant Citrate Dextrose Solution, Solution A (ACDA) 30mL Vials (Supplied in apheresis and surgical procedure kits)

Affected kits:
BIOCUE STD KIT ACD-A W/BD
Product Number: 800-0613A

GPS3 SINGLE KIT W/BLOOD DRAW
Product Number: 800-0675A

GPS BONE BIOLOGICS KIT 20mL + S.TUBE
Product Number: TCP20GPSS.2

MARROWSTIM CALCIBON KIT 20mL
Product Number: TCP20MARROW

BIOCUE CALCIBON KIT 20mL
Product Number: TCP20BIOCUE

ARTG #: 183209, 100053, 127024
Recall Action Level Hospital
Recall Action Classification Class II
Recall Action Commencement Date 1/08/2016
Responsible Entity Zimmer Pty Ltd
Reason/Issue Zimmer Biomet has initiated this action following an investigation which identified a defect with the ACDA 30 ml vial known as a split finish that could compromise product sterility. Split finishes occur during the glass bottle manufacturing process. The data shows that the risk of a sterility breach is rare <1% and the risk of injury to patients is remote <0.1%. Use may result in an infection. There have been no reported complaints to date.
Recall Action Recall
Recall Action Instructions Zimmer Biomet is advising users inspect and quarantine affected stock for return. This action has been closed-out on 02/03/2017.
Contact Information 02 9483 5426 - Zimmer Biomet